Journal
Blood Advances
Publication Date
2018
Volume
2
Issue
14
Inclusive Pages
1705-1718
Document Type
Open Access Publication
DOI
10.1182/bloodadvances.2017015396
Rights and Permissions
Byrd, J. C., Ruppert, A. S., Heerema, N. A., Halvorson, A. E., Hoke, E., Smith, M. R., Godwin, J. E., Couban, S., Fehniger, T. A., Thirman, M. J., Tallman, M. S., Appelbaum, F. R., Stone, R. M., Robinson, S., Chang, J. E., Mandrekar, S. J., & Larson, R. A. (2018). Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance). Blood Advances, 2(14), 1705-1718. https://doi.org/10.1182/bloodadvances.2017015396.
Recommended Citation
Fehniger, Todd A., "Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: Results for CALGB 10404 (Alliance)." Blood Advances. 2, 14. 1705-1718. (2018).
https://digitalcommons.wustl.edu/open_access_pubs/7245
